ESVNF.US E79 Resources Corp
- Market cap
- USD 5.30M
- P/E
- -
- P/B
- 3.34x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jul 2026.
Is ESVNF.US undervalued?
Graham numberThe Graham number of E79 Resources Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
E79 Resources Corp fundamental analysis
No fundamental analysis for E79 Resources Corp yet.
E79 Resources Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About E79 Resources Corp
Apptly Health Technologies Corp. operates a digital healthcare platform in global markets. It offers services that connect patients directly with medical specialists for in-person or virtual consultations, featuring transparent pricing and online booking without the need for insurance or referrals. The company provides access to specialties, such as Cardiology, Dermatology, Orthopedics, and Mental Health, and serves individual patients as well as employers seeking employee h…
Full company profileE79 Resources Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jul 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
E79 Resources Corp annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 47.8K | 46.6K | 121K | 57.5K |
| Gross Profit | - | - | - | 0.00 | -2.94K | -7.06K | -1.84M | - |
| Operating Income | -66.1K | -2.37M | -3.23M | -2.52M | -1.13M | -543K | -5.58M | -3.55M |
| EBITDA | -66.1K | -2.17M | -3.18M | -2.52M | -12.2M | -543K | -5.58M | -2.92M |
| Net Income | -66.1K | -2.56M | -3.28M | -5.54M | -12.4M | -598K | -7.14M | -3.35M |
| EPS | -0.01 | -0.04 | -0.05 | -0.09 | -0.19 | -0.09 | -0.15 | -0.05 |
| Balance Sheet | ||||||||
| Total Assets | 281K | 13.7M | 20.9M | 15.2M | 2.49M | 2.28M | 935K | 126K |
| Total Liabilities | 49.0K | 329K | 1.13M | 357K | 96.3K | 484K | 3.73M | 3.83M |
| Shareholders' Equity | 232K | 13.4M | 19.8M | 14.9M | 2.39M | 1.79M | -2.80M | -3.70M |
| Cash & Short-term Investments | 191K | 4.70M | 8.06M | 4.05M | 2.39M | 1.72M | 704K | 55.9K |
| Total Debt | 13.4K | - | - | - | - | - | 2.24M | - |
| Cash Flow | ||||||||
| Operating Cash Flow | -31.2K | -1.40M | -2.30M | -1.30M | -1.44M | -662K | -2.01M | -2.61M |
| Capital Expenditure | 459.00 | 477K | 2.73M | 2.64M | 222K | 2.41K | 4.08 | 0.00 |
| Free Cash Flow | -31.7K | -1.88M | -5.03M | -3.94M | -1.66M | -665K | -2.01M | -2.61M |
| Ratios | ||||||||
| ROE | -28.4% | -19.1% | -16.5% | -37.2% | -519.6% | -33.4% | - | - |
| ROA | -23.5% | -18.7% | -15.6% | -36.4% | -499.5% | -26.3% | -763.3% | -2,664.7% |
| Net Profit Margin | - | - | - | - | -26,021.0% | -1,285.2% | -5,912.9% | -5,820.4% |
| Debt to Equity | 0.06x | - | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
E79 Resources Corp dividends
E79 Resources Corp has not paid dividends in the last 7 fiscal years.
Last stock split: 1:10 on Jan 10, 2025.
Who owns E79 Resources Corp
- Insiders 28.00%
- Institutions 0.00%
- Public & others 72.00%
- Shares outstanding 61.8M
- Free float 45.8M
E79 Resources Corp company profile
- Company name
- E79 Resources Corp
- Ticker
- ESVNF.US
- ISIN
- CA81752V1013
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Metals & Mining
- Fiscal year end
- April
- Address
- 918 - 1030 West Georgia Street, Vancouver, BC, Canada, V6E 2Y3
- Phone
- 508-319-9712
- Website
- apptlyhealthtech.com
About E79 Resources Corp
Apptly Health Technologies Corp. operates a digital healthcare platform in global markets. It offers services that connect patients directly with medical specialists for in-person or virtual consultations, featuring transparent pricing and online booking without the need for insurance or referrals. The company provides access to specialties, such as Cardiology, Dermatology, Orthopedics, and Mental Health, and serves individual patients as well as employers seeking employee health benefits. It has a strategic partnership with BioNADrx Holdings, Inc. to bring woman-owned cellular-healthinnovator onto the Marketplace. Apptly Health Technologies Corp. was formerly known as UBERDOC Health Technologies Corp. and changed its name to Apptly Health Technologies Corp. in June 2026. The company is based in Vancouver, Canada.
E79 Resources Corp management
3- Mr. Sean KearneyCEO & Director
- Konstantin LichtenwaldCFO & Corporate Secretary
- Mr. Maximillian WhiffinVP of Capital Markets & Director · born 1998